Literature DB >> 24323757

Visualization of the Superparamagnetic Iron Oxide (SPIO)-Labeled Bone Marrow Stromal Cells Using a 3.0-T MRI-a Pilot Study for Clinical Testing of Neurotransplantation.

Hideo Shichinohe1, Satoshi Kuroda, Kohsuke Kudo, Masaki Ito, Masahito Kawabori, Michiyuki Miyamoto, Mitsuhiro Nakanishi, Satoshi Terae, Kiyohiro Houkin.   

Abstract

Recent studies have elucidated that transplantation of the bone marrow stromal cells (BMSC) has therapeutic potential for the central nervous system (CNS) disorders. However, no imaging modalities have been established to track the engrafted cells in the CNS in clinical situation. This study aimed to investigate the ability of magnetic resonance imaging (MRI) to visualize the BMSC labeled with superparamagnetic iron oxide (SPIO). The BMSC of mice were labeled with SPIO. Various numbers of the cells were injected into the agar phantom and were visualized using a 3.0-T MR apparatus. The SPIO-labeled cells were injected into the temperature-sensitive gelation polymer (TGP) hydrogel and were cultured for 7 days. They were also visualized just after the injection and at 7 days postinjection. After a 7-day culture, they were stained with Turnbull blue technique. T2-, T2*-, and susceptibility-weighted imaging could identify minimally 1,000 cells in the agar or TGP hydrogel, although it was difficult to quantify their number on MRI. All of these sequences could track the SPIO-labeled BMSC for at least 7 days when injected into the TGP. Turnbull blue staining revealed the survival and proliferation of the SPIO-labeled BMSC in the TGP for 7 days. The findings strongly suggest that the SPIO labeling may enable to track minimally 1,000 cells engrafted in the CNS on clinical MR apparatus. These data would be valuable to consider the application of imaging technique into cell transplantation therapy for CNS disorders.

Entities:  

Year:  2011        PMID: 24323757     DOI: 10.1007/s12975-011-0138-5

Source DB:  PubMed          Journal:  Transl Stroke Res        ISSN: 1868-4483            Impact factor:   6.829


  36 in total

1.  Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model.

Authors:  Lars M Bjorklund; Rosario Sánchez-Pernaute; Sangmi Chung; Therese Andersson; Iris Yin Ching Chen; Kevin St P McNaught; Anna-Liisa Brownell; Bruce G Jenkins; Claes Wahlestedt; Kwang-Soo Kim; Ole Isacson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-08       Impact factor: 11.205

2.  Autologous mesenchymal stem cell therapy delays the progression of neurological deficits in patients with multiple system atrophy.

Authors:  P H Lee; J W Kim; O Y Bang; Y H Ahn; I S Joo; K Huh
Journal:  Clin Pharmacol Ther       Date:  2007-09-26       Impact factor: 6.875

3.  Effect of biodegradable fibrin scaffold on survival, migration, and differentiation of transplanted bone marrow stromal cells after cortical injury in rats.

Authors:  Hiroshi Yasuda; Satoshi Kuroda; Hideo Shichinohe; Shintaro Kamei; Ryoichi Kawamura; Yoshinobu Iwasaki
Journal:  J Neurosurg       Date:  2010-02       Impact factor: 5.115

4.  Fibrin matrix provides a suitable scaffold for bone marrow stromal cells transplanted into injured spinal cord: a novel material for CNS tissue engineering.

Authors:  Hiroyuki Itosaka; Satoshi Kuroda; Hideo Shichinohe; Hiroshi Yasuda; Shunsuke Yano; Shintaro Kamei; Ryoichi Kawamura; Kazutoshi Hida; Yoshinobu Iwasaki
Journal:  Neuropathology       Date:  2008-10-20       Impact factor: 1.906

5.  Detection of 111In-oxine-labeled bone marrow stromal cells after intravenous or intralesional administration in chronic paraplegic rats.

Authors:  Javier de Haro; Mercedes Zurita; Ladislao Ayllón; Jesús Vaquero
Journal:  Neurosci Lett       Date:  2004-12-15       Impact factor: 3.046

6.  Treatment of traumatic brain injury in female rats with intravenous administration of bone marrow stromal cells.

Authors:  A Mahmood; D Lu; L Wang; Y Li; M Lu; M Chopp
Journal:  Neurosurgery       Date:  2001-11       Impact factor: 4.654

7.  In vivo fluorescence tracking of bone marrow stromal cells transplanted into a pneumatic injury model of rat spinal cord.

Authors:  Shunsuke Yano; Satoshi Kuroda; Jang-Bo Lee; Hideo Shichinohe; Toshitaka Seki; Jun Ikeda; Goro Nishimura; Kazutoshi Hida; Mamoru Tamura; Yoshinobu Iwasaki
Journal:  J Neurotrauma       Date:  2005-08       Impact factor: 5.269

8.  Migration and differentiation of nuclear fluorescence-labeled bone marrow stromal cells after transplantation into cerebral infarct and spinal cord injury in mice.

Authors:  JangBo Lee; Satoshi Kuroda; Hideo Shichinohe; Jun Ikeda; Toshitaka Seki; Kazutoshi Hida; Mitsuhiro Tada; Ken-ichi Sawada; Yoshinobu Iwasaki
Journal:  Neuropathology       Date:  2003-09       Impact factor: 1.906

9.  Bone marrow stromal cells and bone marrow-derived mononuclear cells: which are suitable as cell source of transplantation for mice infarct brain?

Authors:  Hideo Shichinohe; Satoshi Kuroda; Katsuhiko Maruichi; Toshiya Osanai; Taku Sugiyama; Yasuhiro Chiba; Ayumi Yamaguchi; Yoshinobu Iwasaki
Journal:  Neuropathology       Date:  2009-09-07       Impact factor: 1.906

Review 10.  Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury.

Authors:  A M Parr; C H Tator; A Keating
Journal:  Bone Marrow Transplant       Date:  2007-07-02       Impact factor: 5.483

View more
  5 in total

1.  Feasibility and Efficiency of Human Bone Marrow Stromal Cell Culture with Allogeneic Platelet Lysate-Supplementation for Cell Therapy against Stroke.

Authors:  Chengbo Tan; Hideo Shichinohe; Zifeng Wang; Shuji Hamauchi; Takeo Abumiya; Naoki Nakayama; Ken Kazumata; Tsuneo Ito; Kohsuke Kudo; Shigeru Takamoto; Kiyohiro Houkin
Journal:  Stem Cells Int       Date:  2016-10-20       Impact factor: 5.443

Review 2.  Cell Therapy for Stroke: Review of Previous Clinical Trials and Introduction of Our New Trials.

Authors:  Hideo Shichinohe; Kiyohiro Houkin
Journal:  Neurol Med Chir (Tokyo)       Date:  2016-06-10       Impact factor: 1.742

3.  Evaluation of Novel Stereotactic Cannula for Stem Cell Transplantation against Central Nervous System Disease.

Authors:  Masahito Kawabori; Aki Tanimori; Shinri Kitta; Hideo Shichinohe; Kiyohiro Houkin
Journal:  Stem Cells Int       Date:  2020-02-11       Impact factor: 5.443

4.  Mesenchymal Stem Cell Sheet Promotes Functional Recovery and Palliates Neuropathic Pain in a Subacute Spinal Cord Injury Model.

Authors:  Kazuyoshi Yamazaki; Masahito Kawabori; Toshitaka Seki; Soichiro Takamiya; Kotaro Konno; Masahiko Watanabe; Kiyohiro Houkin; Miki Fujimura
Journal:  Stem Cells Int       Date:  2021-07-09       Impact factor: 5.443

5.  Improved sensitivity of cellular MRI using phase-cycled balanced SSFP of ferumoxytol nanocomplex-labeled macrophages at ultrahigh field.

Authors:  Yelong Shen; Lirong Yan; Xingfeng Shao; Bin Zhao; Jinlun Bai; Wange Lu; Danny Jj Wang
Journal:  Int J Nanomedicine       Date:  2018-07-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.